BIOAFFINITY TECHNOLOGIEW-27 (BIAFW) Stock News

USA - Nasdaq - NASDAQ:BIAFW -

0.265 USD

-0.08 (-22.06%)

Last: 11/17/2025, 8:00:01 PM

Technical Analysis

BIAFW Latest News, Press Relases and Analysis

All

Press Releases

8 days ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Third Quarter 2025 Financial Results

17 days ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Accelerating Month-Over-Month Growth in CyPath® Lung Test Volume

25 days ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Acceptance of Australian Patent Application for Platform to Detect and Characterize Multiple Lung Diseases

a month ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Presents Research Supporting CyPath® Lung Processing Methods at CHEST 2025

a month ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Notification of Allowance for U.S. Patent Application for Its Diagnostic Algorithm and Test Method for Lung Cancer

a month ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Regains Compliance with Nasdaq Listing Requirements

a month ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

a month ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies, Inc. Announces Approximately $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Record Growth in CyPath® Lung Test Volume for Third Quarter 2025

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Closing of $4.8 Million Public Offering

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Pricing of $4.8 Million Public Offering

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Adds to Growing Number of Case Studies Demonstrating Clinical Value of CyPath® Lung

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces 1-for-30 Reverse Stock Split Effective at the Open of Trading on September 19, 2025

2 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Case Study: CyPath® Lung Identifies Lung Cancer in Patient with Difficult-to-Diagnose Ground-Glass Pulmonary Nodules

3 months ago - By: bioAffinity Technologies - Mentions: BIAF

U.S. Medicine Magazine Spotlights CyPath® Lung as Promising Tool to Improve Lung Cancer Detection in Veterans, Lower Costs to the VA

3 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Appoints New Members to Board of Directors

3 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Closing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

3 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Second Quarter 2025 Results

3 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Pricing of Private Placement and Warrant Inducement Transaction for Approximately $1.2 Million in Gross Proceeds

3 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Accelerating Growth in CyPath® Lung Test Sales

4 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient With Inconclusive Imaging and Low-Risk Serum Test Results

4 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Case Study: CyPath® Lung Detects Neuroendocrine Tumor Missed by Other Diagnostic Tools

4 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Canada Awards New Patent to bioAffinity Technologies for CyPath® Lung, Company’s Noninvasive Lung Cancer Diagnostic

4 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Notification of China Patent Award for Company’s Noninvasive Lung Cancer Diagnostic

5 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Case Study: CyPath® Lung Detects Stage 1A Lung Cancer in High-Risk Patient with Inconclusive Imaging

5 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Scientists Present Breakthrough Cancer Research at RNA Therapeutics Conference

5 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Expands Patent Portfolio with China Grant for siRNA-Based Cancer Therapy

5 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board

6 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Works With Cardinal Health™ OptiFreight® Logistics to Help Meet Demand for CyPath® Lung

6 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces New U.S. Patent for Novel Broad Spectrum Cancer Therapeutics

6 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Appoints Dr. Gordon Downie, MD, PhD, as Chief Medical Officer

6 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports First Quarter 2025 Results

7 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Closing of $3.25 Million Offering

7 months ago - By: Yahoo Finance - Mentions: BABA BIAF DHI CMG ...

BioAffinity Technologies announces pricing of $3.25M offering

7 months ago - By: Yahoo Finance - Mentions: UBS ROK TJX BIAF ...

Rockwell Automation Lifts Full-Year Profit Outlook Following Second-Quarter Beat

7 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Announces Pricing of $3.25 Million Offering

7 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Increases Efficiency of CyPath® Lung Test by Boosting Data Acquisition Throughput by 50% and Reducing Unit Cost

8 months ago - By: Yahoo Finance - Mentions: GM COMP WAB F

Veteran trader reminds investors of the market crashes through history

8 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

bioAffinity Technologies Reports Record $9.4 Million Revenue for 2024

8 months ago - By: bioAffinity Technologies, Inc. - Mentions: BIAF

Case Study: bioAffinity Technologies’ CyPath® Lung Detects Second Primary Lung Cancer in Patient With History of Lung Cancer